(Total Views: 245)
Posted On: 05/21/2020 7:17:36 AM
Post# of 15389
![Avatar](https://investorshangout.com/images/ProfileImages/754971288_289_stock market picture.jpg)
$PBIO Mr. Keyon Janani, founder and President of Five Leaf Laboratories ("FLL"
, said: "Our hemp-derived, CBD products are made exclusively from organic, pesticide-free, top quality hemp. All existing and pipeline products are focused entirely on the medicinal properties of CBD. We recently released our first set of CBD-infused products to the U.S. market, which were greeted with excellent, widespread acceptance. We attribute the success of our initial launch to both the high quality of our hemp source supply and processing methods, and to the effectiveness of our well-trained, knowledgeable and experienced network of over 50 sales representatives spanning 21 states."
Mr. Janani continued: "We are very excited about the pending merger with Cannaworx for several reasons. First, we are highly impressed with their innovative product line and believe our existing product portfolio will fit in synergistically with theirs quite well. Second, we have a seasoned, large, and very capable sales and distribution network, representing thousands of potential customers for the existing Cannaworx portfolio of products, especially their novel phytocannabinoid formulations for pain relief. At this critical time, as they are preparing for their initial product launch, what could be better than access to our existing customer base and the long reach of our multiple sales and marketing channels."
https://www.wsj.com/articles/PR-CO-20200519-911667
![](/m/images/icons/icon_wink.gif)
Mr. Janani continued: "We are very excited about the pending merger with Cannaworx for several reasons. First, we are highly impressed with their innovative product line and believe our existing product portfolio will fit in synergistically with theirs quite well. Second, we have a seasoned, large, and very capable sales and distribution network, representing thousands of potential customers for the existing Cannaworx portfolio of products, especially their novel phytocannabinoid formulations for pain relief. At this critical time, as they are preparing for their initial product launch, what could be better than access to our existing customer base and the long reach of our multiple sales and marketing channels."
https://www.wsj.com/articles/PR-CO-20200519-911667
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼